Australian Institute of Health and Welfare (2021) Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21, AIHW, Australian Government, accessed 30 May 2023.
Australian Institute of Health and Welfare. (2021). Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21. Retrieved from https://www.aihw.gov.au/reports/primary-health-care/pipqi-measures-national-report-2020-21
Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21. Australian Institute of Health and Welfare, 27 August 2021, https://www.aihw.gov.au/reports/primary-health-care/pipqi-measures-national-report-2020-21
Australian Institute of Health and Welfare. Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21 [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2023 May. 30]. Available from: https://www.aihw.gov.au/reports/primary-health-care/pipqi-measures-national-report-2020-21
Australian Institute of Health and Welfare (AIHW) 2021, Practice Incentives Program Quality Improvement Measures: National report on the first year of data 2020-21, viewed 30 May 2023, https://www.aihw.gov.au/reports/primary-health-care/pipqi-measures-national-report-2020-21
Influenza is a common disease of the respiratory tract. It affects people of all ages. It is estimated that influenza is likely to be associated with more than 3,000 deaths and 13,500 hospitalisations each year in Australia, just in people aged >50 years (ATAGI 2018).
There are a number of groups who are at a higher risk of influenza and its complications. These groups experience higher illness and death associated with influenza than the rest of the population and patients with COPD is one of the vulnerable population groups. Therefore, annual influenza vaccination is strongly recommended for patients with COPD (ATAGI 2018).
People with COPD are considered to be at high risk of complications from influenza. Data from several studies also provide evidence that influenza vaccination has a clinically important protective effect on influenza-related COPD exacerbations, and probably an effect on the total number of exacerbations in COPD patients. The administration of influenza vaccine to persons at risk of complications is the single most important measure in preventing or attenuating influenza infection and preventing mortality. While best practice guidelines recommend annual immunisation, a 15 month interval allows for cases when a client decides to receive a vaccine earlier than recommended (e.g. from a pharmacy), or delay and wait for the release of an ‘enhanced’ vaccine (Department of Health 2020).
Some patients with COPD may receive care from other practitioners in addition to a GP including a specialist physician, and/or other health care providers to safely manage their COPD (Abramson et al. 2014). Results arising from clinical intervention conducted outside of the service that are known and recorded by the practice are included in the measure. Where the immunisation was provided elsewhere (for example, specialist centre, pharmacy, work place etc.) and the information is not recorded in the clinical information system of the client’s usual general practice (for example, due to incompatible clinical information system between a practice and another service), then these data will not be captured in the report.
Data on prevalence of long-term health conditions like COPD are captured in the National Health Survey (NHS) conducted by the Australian Bureau of Statistics (ABS). There are other administrative data collections where the data on influenza immunisation are captured, e.g. the Australian Immunisation Register (AIR).
This indicator reports on the proportion of regular clients aged 15 years and over with a chronic obstructive pulmonary disease (COPD) diagnosis, and who had an influenza immunisation status recorded in their GP record within the previous 15 months.
As of July 2021, nationally, 66.8% of regular clients aged 15 years and over with a COPD diagnosis, and with an influenza immunisation status recoded in their GP record within the previous 15 months. This varied between 52.8% and 75.5% across PHNs.
Nationally, between October 2020 and July 2021, the proportion of regular clients with a COPD diagnosis who had an influenza immunisation status recorded in their GP record within the previous 15 months, increased by 5.9%, from 60.9% to 66.8%.
The development of COPD occurs over many years and therefore affects mainly middle aged and older people. While it is occasionally reported in younger age groups, the prevalence of COPD increases with age, mostly occurring in people aged 45 and over (Abramson et al. 2014). In Australia the prevalence of COPD was estimated to be 7.5% for people aged 40 years and over and 30% for people aged 75 and over (AIHW 2020).
As of July 2021, nationally, the proportion of regular clients aged 15 years and over with a COPD diagnosis, who had an influenza immunisation status recorded in their GP record within the previous 15 months, increased with age and was:
Abramson M, Frith P, Yang I, McDonald C, Hancock K, Jenkins S et al. 2014. COPD-X Concise Guide for Primary Care. Brisbane. Lung Foundation Australia. Viewed 12 August 2021.
AIHW 2020. Chronic obstructive pulmonary disease (COPD). Cat. no. ACM 35. Canberra: AIHW.
Australian Technical Advisory Group on Immunisation (ATAGI) 2018. Australian Immunisation Handbook, Australian Government Department of Health, Canberra. Viewed 12 August 2021.
Department of Health 2017. National Key Performance Indicators for Aboriginal and Torres Strait Islander primary health care - Data Validation Project Report. Canberra: Department of Health.
Department of Health 2020. PIPQI Improvement Measures Technical Specification v1.2 22102020. Viewed 12 August 2021.
This website needs JavaScript enabled in order to work correctly; currently it looks like it is disabled. Please enable JavaScript to use this website as intended.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.